U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07881770) titled 'Semaglutide Health Outcomes and Patient Adherence in Australia' on Oct. 13.
Brief Summary: This observational study aims to generate real-world evidence on the use of semaglutide in adults with overweight or obesity receiving care through a digital weight loss service (DWLS) programme in Australia. The study will evaluate treatment patterns, adherence, quality of life, safety, and other health outcomes associated with semaglutide use in routine clinical practice. Information will be collected from data generated during standard clinical care, and no study-specific treatment or procedures will be required.
Study Start Date: Oct. 13...